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Abstract: There are limited data on the relationship of acute dental infections with hospitalisation
and new-onset atrial fibrillation (AF). This study aimed to assess the relationship between acute
periapical abscess and incident AF. This was a retrospective cohort study from a French national
database of patients hospitalized in 2013 (3.4 million patients) with at least five years of follow up. In
total, 3,056,291 adults (55.1% female) required hospital admission in French hospitals in 2013 while
not having a history of AF. Of 4693 patients classified as having dental periapical abscess, 435 (9.27%)
developed AF, compared to 326,241 (10.69%) without dental periapical abscess that developed AF
over a mean follow-up of 4.8 ± 1.7 years. Multivariable analysis indicated that dental periapical
abscess acted as an independent predictor for new onset AF (p < 0.01). The CHA2DS2VASc score in
patients with acute dental periapical abscess had moderate predictive value for development of AF,
with Area Under the Curve (AUC) 0.73 (95% CI, 0.71–0.76). An increased risk of new onset AF was
identified for individuals hospitalized with dental periapical abscess. Careful follow up of patients
with severe, acute dental periapical infections is needed for incident AF, as well as investigations of
possible mechanisms linking these conditions.
Keywords: atrial fibrillation; periapical abscess; oral health; acute dental infection; cardiovascu-
lar disease
1. Introduction
Atrial Fibrillation (AF) is the commonest cardiac rhythm disorder (affecting about
1–3% of the population) [1,2]. Sufferers are 3–5 times more times likely to develop stroke,
heart failure and myocardial infarction [3]. Although people with AF can suffer a variety
of symptoms such as chest pain, dizziness and fatigue, many patients are asymptomatic
and only present late with advanced and serious heart problems or a stroke [4]. Population
screening programmes are therefore important to pick up cases early. Although AF rep-
resents a significant cause of population mortality and morbidity, as well as health care
expenditure, the latter is set to escalate due to an ageing population profile given that AF
is more prevalent in older people [4]. There are many risk factors for AF, such as: ageing,
sex (male), diabetes mellitus, and hypertension [5]. However, many of the risk factors
associated with AF are also linked to poor oral health. Indeed, the latter may be a potential
causative factor for AF since inflammatory markers generated by oral diseases are found
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to have a direct effect on the cellular function and electrophysiological remodelling of the
heart [6,7].
The main oral disease which has so far been studied in relation to CVD is periodontitis,
which is defined as inflammation of the gums and destruction of the surrounding bone.
Most adults have some form of gum disease and 11.2% have suffer with severe periodonti-
tis [8]. Severe periodontal disease and tooth loss together affects around 3.9 billion people
globally and is estimated as the 6th most frequent global disease [9,10]. Studies show
biomarkers such as IL-6 and CRP, which are implicated in both cardiovascular disease
(CVD) and periodontitis, are linked to AF [11,12]. Other studies also report a reduction
in inflammation following periodontal treatment [13,14], giving rise to a consensus that
there is moderate evidence of a decrease in inflammatory biomarkers following treatment
of periodontitis [15].
More recently, oral diseases related to CVD apart from periodontitis have also been
investigated, such as apical (or periapical) periodontitis, which is an infection of the tooth
and root canal system leading to destruction of the surrounding tissues [16]. More than half
the population have been found to have apical periodontitis on at least one tooth, which
is often presented as a chronic disease [17]. A systematic review reported an association
between CVD and chronic apical infection, which suggests that while oral infections elicit
a local tissue response, there are wider, systemic effects [18]. However, the primary studies
included in the review only studied asymptomatic and chronic apical infections diagnosed
through radiographic imaging, and AF was not included as separate entity within the
study of CVD effects. Studies investigating oral diseases with CVD do not generally
include AF as an outcome for analysis, although one recent retrospective study found that
patients with a history of AF had a statistically significant incidence of diagnosed apical
infection [19]. Of note, there is a positive association for reduced endothelial function with
chronic apical infections [19,20] (and participants were also free of periodontitis), and given
the associations between AF and endothelial dysfunction, this may have implications for
increasing AF incidence [21].
There are a few retrospective cohort studies linking oral diseases with AF [22–24].
A recent 17-year longitudinal study has also found severe periodontitis with higher as-
sociations with AF (multivariable adjusted HR, 1.31, 95% CI, 1.06–1.62) [25]. One case
report described a patient admitted with acute dental abscess and urticaria, that had also
developed persistent AF, although the AF diagnosis could have been a coincidence [26].
Thus far, studies have only focused on asymptomatic, chronic low-grade inflammatory
processes associated with oral disease, such as chronic periodontitis, rather than symp-
tomatic or severe dental infections [23], although a recent systematic review [27] concluded
there is a need for further research in this area. Incidence of acute dental infections and hos-
pital attendance are common; 5–46% of all people suffer with an acute periapical abscess in
their lifetime and 0.7% of all emergency attendances are related to dental problems [28–30].
Acute periapical abscess is more prevalent for people in disadvantaged groups and can
have a significant impact causing sleepless nights, missed work and reduced quality of
life [31].
In the present study, we aimed to investigate the relationship of acute dental periapical
abscess with new-onset AF in a nationwide cohort study. We tested the hypothesis that
acute periapical abscess is associated with incident AF, in relation to risk strata (using
the CHA2DS2VASc score) using data from the French national hospital database from the
Program de Médicalisation des Systèmes d’Information (PMSI) [32].
2. Materials and Methods
2.1. Study Design
This was a retrospective longitudinal cohort study which covers the full population
and admissions across 1546 hospitals in France. All patients in France are discharged using
the PMSI database and categorised with codes relating to diagnosis and treatment, as in
the US Medicare system [33]. Patients are linked with unique identifiers for multiple ad-
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missions, ensuring the data remains anonymised. The inpatient International Classification
of Diseases (ICD) codes were captured and commonly used for gathering large amounts of
data [34].
The population for analysis was taken from French hospitals using the PMSI database,
which included adults who were admitted from 01 January until 31 December 2013 and had
at least five years of follow up, unless deceased. The Tenth Revision codes, International
Classification of Diseases (ICD-10 codes) were used to identify primary and secondary
diagnosis specified as infection inside and surrounding the root of the tooth and including
hospital admission (dental periapical abscess K04.6, K04.7) [35]. After exclusion of patients
with a history of previous AF, patients were followed up for new-onset AF with hospitalisa-
tion using ICD-10 codes. Identifying AF using an electronic database is considered reliable,
and PMSI data have been evaluated in previous studies [32,36]. Baseline characteristics
from patients hospitalised during 2013 with or without dental periapical abscesses were
recorded, in addition to age, gender, and medical history. Events and predictors for AF
were monitored with at least 5 years follow up. We also calculated the CHA2DS2VASc score
(congestive heart failure, high blood pressure, diabetes, stroke, heart disease, age, gender)
which is used for stroke risk stratification, but used this to stratify risk for new-onset AF
where acute periapical abscess was present [34–37].
2.2. Ethical Approval
The research database involved a collection of non-identifiable information used
for data analysis with external researchers. The study was conducted retrospectively
and, as patients were not involved in its conduct, there was no impact on their care.
Studies such as this study have been labelled as clinical audits, therefore sponsorship
was not required from the University of Liverpool or the University of Tours [32,37,38].
Comparable to previous articles, informed consent was not obtained as the data were
retrospective [22,23]. All patient information remained confidential and anonymised. The
French law allows approval of certain public institutions, such as large university hospitals,
to self-declare authorisation and access to confidential information when using electronic
data for research purposes. The French Data Protection Authority have granted access to
the PMSI data between 2008 and 2015, for the purpose of assessing the prevalence and
incidence of cardiovascular diseases and their complications to the University of Tours in
France. Procedures for data collection and management were approved by the Commission
Nationale de l’Informatique et des Libertés (CNIL), the independent National Ethical
Committee protecting human rights in France, which ensures that all information is kept
confidential and anonymous (authorisation number 1897139).
2.3. Statistical Analysis
Baseline characteristics of patients were given as patient number (N) and percentages
(%), or mean ± standard deviation, and included CHA2DS2VASc scores with average
year follow ups using mean, median and interquartile range. Predictors for new-onset AF
were calculated during follow up for the whole population and for patients with dental
periapical abscess, which were assessed using univariate and multivariable Cox regression
models. For patients with no previous dental periapical abscess, data were censored in case
of dental periapical abscess during follow-up at the date of this event. Incidence and hazard
ratio predictions, with confidence interval (95% CI) and p value (<0.05) for new-onset atrial
fibrillation were calculated in patients with dental periapical abscess during follow up,
using different CHA2DS2VASc scores. The specificity and sensitivity for CHA2DS2VASc
scores as a predictor for new-onset AF and dental periapical abscess were examined further
by plotting the Area Under the Curve-Receiver Operating Characteristic (AUC-ROC). All
comparisons with p < 0.05 were considered statistically significant. All analyses were
performed using Enterprise Guide 7.1, (SAS Institute Inc., SAS Campus Drive, Cary, NC,
USA), USA and STATA version 12.0 (Stata Corp, College Station, TX, USA).
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3. Results
In total, 3,381,472 patients were identified in French hospitals during 2013 that at-
tended emergency services and required hospital admission. The study population in-
cluded at least five years of follow-up, unless deceased, and excluded patients with history
of previous AF. A flowchart of study enrolment is shown in Figure 1. Of patients at baseline,
4693 were identified with a history of dental periapical abscess requiring hospitalisation.
During a mean follow up period of 4.8 ± 1.7 years (median 5.5, IQR 5.1–5.8 years), there
were 435 (9.27%) patients with a history of dental periapical abscess that were diagnosed
with new-onset AF, compared to 326,241 (10.69%) without dental periapical abscess that
developed AF.
Figure 1. Flow chart of the study patients.
Baseline characteristics of patients are shown in Table 1. Patients with a history
of a dental periapical abscess were older (p value < 0.0001) and were more often male
(p value < 0.0001). The prevalence of comorbidities for patients with dental periapical
abscess was higher, including hypertension, diabetes mellitus, heart failure, obesity, alcohol
related diagnosis, chronic kidney disease, and lung disease (p value < 0.0001, respectively).
As shown in Table 2, CHA2DS2VASc scores were higher for those with periapical abscess
at baseline (p value < 0.01).
The multivariable analysis represented in Table 3 found periapical abscess to be an
independent predictor for new-onset AF, hazard ratio (HR) 1.11 (95% confidence interval
(CI), 1.01–1.22). Other significant predictors for new-onset AF included, among others,
older age, male sex, hypertension, diabetes mellitus, heart failure, aortic stenosis, obesity,
and smoking (p value < 0.0001, respectively). For patients with a dental periapical abscess,
there were positive associations for new-onset AF with older age, male sex, hypertension,
aortic regurgitation, dilated cardiomyopathy, previous pacemaker or defibrillator and
inflammatory disease (all p value < 0.05) using multivariable analysis, see Table 4.
The incidence (per 100 person-years) of new-onset AF generally increased with higher
CHA2DS2VASc scores for patients with a history of dental periapical abscess, see Table 5.
The HRs for new-onset AF in patients with dental periapical abscess using different
CHA2DS2VASc scores (in comparison to patients with a score of zero) are shown in Table 6.
As expected, patients with a CHA2DS2VASc score 8 had the highest HR of 34.2.0 (95% CI,
8.3–140.8).
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Table 1. Baseline characteristics of patients seen in French hospitals in 2013 at least 5 years of follow-up (mean follow-up 4.8
± 1.7 years, median 5.5, IQR 5.1–5.8 years).
No Periapical Abscess Periapical Abscess p Total
(n = 3,051,598) (n = 4693) (n = 3,056,291)
Age, years 57.3 ± 21.4 51.7 ± 19.6 <0.0001 57.2 ± 21.4
Gender (male) 1,399,638 (45.9) 2484 (52.9) <0.0001 1,402,122 (45.9)
Hypertension 808,382 (26.5) 1345 (28.7) 0.001 809,727 (26.5)
Diabetes mellitus 382,586 (12.5) 848 (18.1) <0.0001 383,434 (12.5)
Heart failure 18,981 (18.9) 94 (20.9) 0.26 19,075 (18.9)
History of pulmonary edema 14,666 (0.5) 30 (0.6) 0.12 14,696 (0.5)
Valve disease 65,436 (2.1) 188 (4.0) <0.0001 65,624 (2.1)
Aortic stenosis 28,003 (0.9) 83 (1.8) <0.0001 28,086 (0.9)
Aortic regurgitation 12,796 (0.4) 35 (0.7) 0.001 12,831 (0.4)
Mitral regurgitation 23,458 (0.8) 68 (1.4) <0.0001 23,526 (0.8)
Previous endocarditis 2417 (0.1) 42 (0.9) <0.0001 2459 (0.1)
Dilated cardiomyopathy 41,195 (1.3) 107 (2.3) <0.0001 41,302 (1.4)
Coronary artery disease 260,194 (8.5) 519 (11.1) <0.0001 260,713 (8.5)
Previous myocardial infarction 43,172 (1.4) 78 (1.7) 0.15 43,250 (1.4)
Previous PCI 71,028 (2.3) 130 (2.8) 0.04 71,158 (2.3)
Previous CABG 6768 (0.2) 21 (0.4) 0.001 6789 (0.2)
Vascular disease 218,697 (7.2) 479 (10.2) <0.0001 219,176 (7.2)
Previous pacemaker or ICD 53,716 (1.8) 98 (2.1) 0.09 53,814 (1.8)
Ischemic stroke 42,238 (1.4) 76 (1.6) 0.17 42,314 (1.4)
Intracranial bleeding 26,915 (0.9) 51 (1.1) 0.13 26,966 (0.9)
Smoker 207,727 (6.8) 892 (19.0) <0.0001 208,619 (6.8)
Dyslipidemia 357,903 (11.7) 687 (14.6) <0.0001 358,590 (11.7)
Obesity 299,091 (9.8) 579 (12.3) <0.0001 299,670 (9.8)
Alcohol related diagnoses 167,392 (5.5) 703 (15.0) <0.0001 168,095 (5.5)
Chronic kidney disease 83,601 (2.7) 176 (3.8) <0.0001 83,777 (2.7)
Lung disease 266,460 (8.7) 670 (14.3) <0.0001 267,130 (8.7)
Sleep apnoea syndrome 108,409 (3.6) 184 (3.9) 0.17 108,593 (3.6)
COPD 139,929 (4.6) 375 (8.0) <0.0001 140,304 (4.6)
Liver disease 99,391 (3.3) 398 (8.5) <0.0001 99,789 (3.3)
Gastroesophageal reflux 102,057 (3.3) 149 (3.2) 0.52 102,206 (3.3)
Thyroid diseases 139,843 (4.6) 267 (5.7) 0.0003 140,110 (4.6)
Inflammatory disease 152,875 (5.0) 426 (9.1) <0.0001 153,301 (5.0)
Anaemia 217,291 (7.1) 604 (12.9) <0.0001 217,895 (7.1)
Previous cancer 443,622 (14.5) 734 (15.6) 0.03 444,356 (14.5)
Poor nutrition 98,432 (3.2) 339 (7.2) <0.0001 98,771 (3.2)
Cognitive impairment 84,244 (2.8) 163 (3.5) 0.003 84,407 (2.8)
Illicit drug use 13,101 (0.4) 135 (2.9) <0.0001 13,236 (0.4)
CHA2DS2VASc score 1.6 ± 1.3 1.5 ± 1.4 <0.0001 1.6 ± 1.3
Death during follow-up 745,315 (24.4) 1234 (26.3) 0.003 746,549 (24.4)
Cardiovascular death 130,554 (4.3) 176 (3.8) 0.07 130,730 (4.3)
Atrial fibrillation during follow-up 326,644 (10.7) 435 (9.3) 0.001 327,079 (10.7)
Values are n (%) or mean ± SD. CABG = coronary artery bypass graft; COPD = chronic obstructive pulmonary disease; PCI = percutaneous
coronary intervention; SD = standard deviation.
Table 2. CHA2DS2VASc score at baseline in patients seen in French hospitals in 2013 at least 5 years
of follow-up (mean follow-up 4.8 ± 1.7 years, median 5.5, IQR 5.1–5.8 years).
No Periapical Abscess Periapical Abscess
Variables (n = 3,051,598) (n = 4693)
Age, years 57.3 ± 21.4 51.7 ± 19.6
CHA2DS2VASc score 1.6 ± 1.3 1.5 ± 1.4
CHA2DS2VASc score, n (%)
Score = 0 626,912 20.54 % 1284 27.36 %
Score = 1 1,175,581 38.52 % 1718 36.61 %
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Table 2. Cont.
No Periapical Abscess Periapical Abscess
Variables (n = 3,051,598) (n = 4693)
Score = 2 546,836 17.92 % 689 14.68 %
Score = 3 426,115 13.96 % 507 10.8 %
Score = 4 172,369 5.65 % 293 6.24 %
Score = 5 73,417 2.41 % 134 2.86 %
Score = 6 23,678 0.78 % 51 1.09 %
Score = 7 5683 0.19 % 12 0.26 %
Score = 8 875 0.03 % 4 0.09 %
Score = 9 132 0 % 1 0.02 %
Table 3. Predictors of new-onset atrial fibrillation during follow-up in the whole population
of patients seen in French hospitals in 2013 with at least 5 years of follow-up (mean follow-up
4.8 ± 1.7 years, median 5.5, IQR 5.1–5.8 years).
Univariate Analysis Multivariable Analysis
HR, 95%CI p HR, 95%CI p
Age, years 1.077 (1.076–1.077) <0.0001 1.076 (1.075–1.076) <0.0001
Gender (male) 1.640 (1.629–1.651) <0.0001 1.498 (1.487–1.509) <0.0001
Hypertension 2.849 (2.829–2.869) <0.0001 1.114 (1.105–1.123) <0.0001
Diabetes mellitus 1.951 (1.935–1.968) <0.0001 1.106 (1.096–1.116) <0.0001
Heart failure 3.893 (3.857–3.930) <0.0001 1.434 (1.416–1.452) <0.0001
History of pulmonary edema 2.978 (2.862–3.099) <0.0001 1.155 (1.108–1.203) <0.0001
Aortic stenosis 4.862 (4.763–4.963) <0.0001 1.406 (1.376–1.436) <0.0001
Aortic regurgitation 3.343 (3.237–3.453) <0.0001 1.131 (1.094–1.170) <0.0001
Mitral regurgitation 3.580 (3.496–3.665) <0.0001 1.298 (1.266–1.332) <0.0001
Previous endocarditis 2.970 (2.735–3.225) <0.0001 1.343 (1.236–1.459) <0.0001
Dilated cardiomyopathy 3.321 (3.260–3.383) <0.0001 1.236 (1.211–1.262) <0.0001
Coronary artery disease 2.805 (2.780–2.830) <0.0001 1.110 (1.097–1.124) <0.0001
Previous myocardial infarction 2.128 (2.082–2.176) <0.0001 0.903 (0.880–0.926) <0.0001
Previous PCI 2.043 (2.010–2.077) <0.0001 0.888 (0.871–0.906) <0.0001
Vascular disease 2.521 (2.496–2.546) <0.0001 1.091 (1.078–1.104) <0.0001
Sinus node disease 3.903 (3.781–4.029) <0.0001 1.200 (1.161–1.240) <0.0001
Previous pacemaker or ICD 4.423 (4.357–4.490) <0.0001 1.319 (1.298–1.340) <0.0001
Ischemic stroke 2.289 (2.239–2.340) <0.0001 1.140 (1.114–1.165) <0.0001
Intracranial bleeding 1.374 (1.322–1.427) <0.0001 0.885 (0.852–0.920) <0.0001
Smoker 0.903 (0.891–0.917) <0.0001 1.052 (1.036–1.069) <0.0001
Dyslipidemia 1.835 (1.819–1.851) <0.0001 0.879 (0.871–0.888) <0.0001
Obesity 1.385 (1.371–1.399) <0.0001 1.270 (1.256–1.285) <0.0001
Alcohol related diagnoses 0.991 (0.975–1.006) 0.24 1.289 (1.267–1.312) <0.0001
Chronic kidney disease 2.516 (2.480–2.554) <0.0001 1.262 (1.243–1.282) <0.0001
Lung disease 1.885 (1.866–1.905) <0.0001 1.108 (1.090–1.126) <0.0001
Sleep apnoea syndrome 1.579 (1.556–1.603) <0.0001 1.115 (1.098–1.133) <0.0001
COPD 2.316 (2.287–2.344) <0.0001 1.111 (1.089–1.133) <0.0001
Liver disease 1.141 (1.119–1.164) <0.0001 1.082 (1.059–1.105) <0.0001
Gastroesophageal reflux 0.756 (0.740–0.772) <0.0001 0.804 (0.787–0.821) <0.0001
Thyroid diseases 1.316 (1.297–1.336) <0.0001 0.985 (0.970–0.999) 0.04
Inflammatory disease 1.036 (1.020–1.052) <0.0001 0.978 (0.964–0.994) 0.005
Anaemia 1.772 (1.751–1.793) <0.0001 1.082 (1.068–1.095) <0.0001
Previous cancer 1.602 (1.587–1.617) <0.0001 1.055 (1.045–1.065) <0.0001
Poor nutrition 1.775 (1.744–1.807) <0.0001 0.951 (0.934–0.969) <0.0001
Cognitive impairment 2.368 (2.326–2.410) <0.0001 0.821 (0.807–0.836) <0.0001
Illicit drug use 0.288 (0.263–0.317) <0.0001 0.940 (0.855–1.032) 0.19
Periapical abscess 0.855 (0.778–0.939) 0.001 1.107 (1.008–1.216) 0.03
COPD = chronic obstructive pulmonary disease; PCI = percutaneous coronary intervention.
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Table 4. Predictors of new-onset atrial fibrillation during follow-up in patients with periapical abscess
seen in French hospitals in 2013 with at least 5 years of follow-up (mean follow-up 4.8 ± 1.7 years,
median 5.5, IQR 5.1–5.8 years).
Univariate Analysis Multivariable Analysis
HR, 95%CI p HR, 95%CI p
Age, years 1.074 (1.067–1.081) <0.0001 1.068 (1.061–1.075) <0.0001
Gender (male) 1.475 (1.216–1.789) <0.0001 1.580 (1.324–1.885) <0.0001
Hypertension 3.877 (3.202–4.695) <0.0001 1.234 (1.020–1.493) 0.03
Diabetes mellitus 1.798 (1.456–2.220) <0.0001 1.173 (0.954–1.442) 0.13
Heart failure 4.014 (3.217–5.008) <0.0001 1.200 (0.898–1.603) 0.22
History of pulmonary edema 1.803 (0.579–5.613) 0.31 0.483 (0.171–1.365) 0.17
Aortic stenosis 6.962 (4.796–10.106) <0.0001 1.130 (0.690–1.850) 0.63
Aortic regurgitation 2.246 (1.062–4.751) 0.03 2.038 (1.108–3.749) 0.02
Mitral regurgitation 4.721 (3.072–7.255) <0.0001 1.080 (0.604–1.930) 0.80
Previous endocarditis 4.097 (2.307–7.275) <0.0001 2.839 (0.955–8.443) 0.06
Dilated cardiomyopathy 3.324 (2.216–4.987) <0.0001 1.973 (1.273–3.058) 0.002
Coronary artery disease 3.493 (2.825–4.319) <0.0001 1.158 (0.886–1.512) 0.28
Previous myocardial infarction 2.767 (1.745–4.390) <0.0001 0.762 (0.434–1.337) 0.34
Previous PCI 2.428 (1.643–3.587) <0.0001 0.814 (0.519–1.275) 0.37
Vascular disease 3.241 (2.602–4.036) <0.0001 1.036 (0.793–1.353) 0.80
Sinus node disease 5.828 (3.165–10.729) <0.0001 1.628 (0.875–3.032) 0.12
Previous pacemaker or ICD 4.542 (3.074–6.711) <0.0001 1.758 (1.242–2.488) 0.001
Ischemic stroke 3.096 (1.849–5.186) <0.0001 1.233 (0.796–1.909) 0.35
Intracranial bleeding 1.045 (0.391–2.799) 0.93 0.773 (0.319–1.873) 0.57
Smoker 0.680 (0.517–0.895) 0.006 1.059 (0.782–1.434) 0.71
Dyslipidemia 2.153 (1.735–2.671) <0.0001 0.757 (0.601–0.953) 0.02
Obesity 1.803 (1.428–2.277) <0.0001 1.080 (0.846–1.380) 0.54
Alcohol related diagnoses 0.731 (0.540–0.990) 0.04 1.181 (0.857–1.629) 0.31
Chronic kidney disease 2.735 (1.950–3.835) <0.0001 1.229 (0.888–1.701) 0.21
Lung disease 1.453 (1.134–1.861) 0.003 1.161 (0.815–1.653) 0.41
Sleep apnoea syndrome 2.141 (1.514–3.026) <0.0001 0.943 (0.673–1.322) 0.74
COPD 2.120 (1.601–2.808) <0.0001 0.948 (0.612–1.469) 0.81
Liver disease 1.068 (0.752–1.516) 0.71 1.134 (0.778–1.653) 0.51
Gastroesophageal reflux 0.788 (0.443–1.400) 0.42 1.060 (0.672–1.671) 0.80
Thyroid diseases 1.361 (0.954–1.941) 0.09 1.119 (0.788–1.590) 0.53
Inflammatory disease 0.956 (0.693–1.320) 0.79 1.416 (1.079–1.859) 0.01
Anaemia 1.587 (1.217–2.068) 0.001 0.881 (0.660–1.176) 0.39
Previous cancer 1.738 (1.349–2.239) <0.0001 0.999 (0.801–1.246) 0.99
Poor nutrition 1.329 (0.926–1.907) 0.12 0.755 (0.467–1.221) 0.25
Cognitive impairment 1.565 (0.963–2.545) 0.07 0.678 (0.439–1.047) 0.08
Illicit drug use 0.447 (0.200–1.001) 0.05 0.449 (0.110–1.831) 0.26
COPD = chronic obstructive pulmonary disease; PCI = percutaneous coronary intervention.
Table 5. Incidence (per 100 person-years) of new-onset atrial fibrillation with different CHA2DS2VASc
scores in patients with periapical abscess seen in French hospitals in 2013 with at least 5 years of











Score = 0 1284 6413.57 48 0.748 (0.564–0.993)
Score = 1 1718 8643.09 65 0.752 (0.590–0.959)
Score = 2 689 2927.79 91 3.108 (2.531–3.817)
Score = 3 507 1930.53 98 5.076 (4.165–6.188)
Score = 4 293 1109.12 73 6.582 (5.233–8.279)
Score = 5 134 405.27 43 10.610 (7.869–14.306)
Score = 6 51 172.17 11 6.389 (3.538–11.537)
Score = 7 12 40.15 4 9.964 (3.740–26.547)
Score = 8 4 8.27 2 24.172 (6.045–96.649)
Score = 9 1 0.16 0 0.000
Total 4693 21,650.12 435 2.009 (1.829–2.207)
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Table 6. Hazard ratio of new-onset atrial fibrillation in patients with acute dental periapical abscess








Score = 0 (reference) 1257 48 1 -
Score = 1 1708 65 0.983 (0.677–1.428) 0.93
Score = 2 690 91 4.056 (2.859–5.755) <0.0001
Score = 3 531 98 6.353 (4.494–8.983) <0.0001
Score = 4 371 73 8.616 (5.983–12.408) <0.0001
Score = 5 190 43 13.315 (8.808–20.129) <0.0001
Score = 6 84 11 8.289 (4.300–15.979) <0.0001
Score = 7 20 4 6.205 (2.063–18.657) 0.001
Score = 8 5 2 34.189 (8.300–140.835) <0.0001
Score = 9 1 0 - -
Figure 2 illustrates that the CHA2DS2VASc scores had an intermediate predictive
value for incident AF amongst patients with a history of dental periapical abscess, with
AUC 0.73 (95% CI, 0.71–0.76). This AUC correctly predicted 79.2% of patients for new-onset
AF with CHA2DS2VASc score ≥ 3 with a specificity of patients at 53.1% and sensitivity
81.9%. CHA2DS2VASc scores ≥ 2 were correctly classified at 68.4%, with sensitivity of
74.0% and specificity of 67.9%.
Figure 2. Cont.
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Figure 2. (a) CHA2DS2VASc score and prediction of new-onset AF and (b) correctly classified
individual by CHA2DS2VASc scores.
4. Discussion
In this study to investigate the occurrence of new-onset AF in patients who were
hospitalised because of a dental periapical abscess, our principal findings are as follows:
(i) dental periapical abscess acted as an independent predictor for new onset AF; (ii)
the CHA2DS2VASc score in patients with acute dental periapical abscess has significant
predictive value for incident AF; and (iii) other associations of new-onset AF during follow-
up in patients with dental periapical abscess were older age, male sex, hypertension,
aortic regurgitation, dilated cardiomyopathy, previous pacemaker or defibrillator and
inflammatory disease.
To our knowledge, this is the first study to investigate patients with acute dental infec-
tions and hospitalisation, as a population-based cohort study for new-onset AF, although as
discussed previously, a recent systematic review by Hassan et al. has summarised that there
is a need for more research in this area [27]. This is important given that hospitalisations
because of dental abscesses are not uncommon—for example, a retrospective analysis in
the United States found that over 61,000 patients had been hospitalised for this reason over
an 8 year period, and a total of 66 people had died [39].
Although outwith the main empirical focus of our paper, it is useful to consider
biological plausibility and the evidence for possible mechanisms linking acute dental infec-
tions to AF. Dental periapical abscess represents an immune response from infected pulp
tissue mainly due to Streptococcus, Prevotella and Fusobacterium species [40]. The pres-
ence of different Gram-positive and Gram-negative oral bacteria induce conflict between
microbial pathogens and host immune system, resulting in severe pain and destruction
of the surrounding dental tissues [41,42]. The presence of different Gram-positive and
Gram-negative oral bacteria in the bloodstream can induce cytokines interleukin-1 (IL-1
β), tumour necrosis factor (TNF-α) and metalloproteinases (MMPs), leading to a dysregu-
lated acute response, and in some instances leading to sepsis, a common life-threatening
complication when the body’s immune system responds to infection and injures its own
tissues and organs [43–45]. It is also known that proinflammatory markers (IL-1, TNF-α)
and MMPs associated with acute dental infections and cellular remodelling are expressed
during occurrence of AF [46–48]. The mechanisms that are expressed during dental peri-
apical abscess may be consequential to the heart, even if the infection is resolved. Other
articles have shown that some types of severe infection, such as sepsis, are associated with
new-onset AF, although it is not clear in this study how many patients with hospitalised
dental periapical abscess have also suffered with sepsis, therefore more research is needed
in this area to understand the impact [49,50].
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The CHA2DS2VASc score is a validated clinical tool used to predict the risk of stroke
and thromboembolism for patients with confirmed diagnosis of AF [51]. Given that the
CHA2DS2VASc is a cluster of common cardiovascular risk factors, the score also has
been reported to predict adverse events for patients without AF, such as mortality, stroke,
cardiovascular events, and subsequent diagnosis of AF [37,52,53]. Prior studies that have
investigated oral diseases and AF have never previously evaluated the CHA2DS2VASc
score as a prediction tool for new-onset AF. Our results suggest that CHA2DS2VASc score
may have modest predictive value for predicting AF, as in the general population without
oral sepsis. Nonetheless, the CHA2DS2VASc score was not proposed to predict AF, but to
risk stratify for stroke, which may suggest a weakness for the AUC score and design.
4.1. Clinical Implications
With an ageing population demographic predicted to involve 25% being over 60 by
2050, more of whom are likely to retain their teeth into old age; and with AF being more
prevalent with increased age, implications of links between poor oral health and CVD
and AF are of concern to the dental profession and the health system in general [54,55].
Moreover, since the COVID-19 pandemic has led to suspension of routine dental services
in many parts of the world since restoring teeth involves aerosol generating procedures,
increased numbers of people are attending services with oral and dental infections [56].
Interventions through improving oral health or signposting and screening for AF and CVD
may help improve patient care, prevent severe cardiovascular complication, and reduce
health care expenditure across the system. Finally, investigating different biomarkers for
both acute and chronic oral diseases and their relationship with AF may serve as a unique
model for understanding different inflammatory pathways and their relationship with AF
and AF-related complications.
4.2. Limitations
We investigated dental infection using a hospital database, and although this enables
us to monitor large amounts of data, a major limitation is its retrospective design, and it
does not imply cause or effect. As in previous studies, our study defined diagnosis of new-
onset AF during hospitalisation, rather than using detailed investigations or outpatient
appointments, meaning it could underestimate the true incidence of AF. Unadjusted
incidence rate of AF was lower in patients with dental periapical abscess, but these patients
were markedly younger. We thus used multivariable analysis to account for differences in
age and prevalent comorbidities associated with AF for the study population. Although
we found dental abscess to be an independent risk factor using multivariable analysis,
there may have been some confounders missing from the dataset. Nonetheless, our data
accounted for more potential confounders (such as smoking, obesity and alcohol related
diagnosis) which have been a limitation for other prior studies investigating oral diseases
and AF [22–24].
Another possible limitation is that even though we accounted for selection-bias using
a nationwide database with the French population, different codes may be more common
in different countries and that the data presented may not be generalisable. A cross
sectional study in England found dental problems accounted for 0.7% of all attendees
in emergency departments and “dental unspecified”, “dental abscess” and “toothache”
and were the most common codes used [30]. Currie et al. [30] went on to explain that the
true number of patients attending with acute dental periapical abscess may have been
underrepresented due to non-dental healthcare staff using codes “dental unspecified” and
general abscess (rather than dental). It was not possible to check the categorisation of
“periapical abscess” with dental imaging to confirm diagnosis, but we attempted to rectify
this problem by excluding other codes used apart from “dental periapical abscess”, which
we felt healthcare staff would not have coded unless confident of the diagnosis for the
patient. We only included patients that were hospitalised, meaning they were likely to
be managed under healthcare staff with specialty knowledge of diagnosing and treating
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the patient. Dental periapical abscess was included as a primary and secondary diagnosis
because even as an additional finding, it would still mean the dental periapical abscess was
also a problem if a hospital needed to investigate and diagnose it clinically.
5. Conclusions
Our results from this population-based cohort study demonstrate an increased risk of
new onset AF for individuals hospitalised with dental periapical abscess. Careful follow
up of patients with severe, acute dental infections is needed for incident AF, as well as
investigations of possible mechanisms linking these conditions.
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